GHK-Cu
A naturally occurring copper-binding tripeptide with demonstrated roles in tissue remodeling, skin regeneration, and wound healing across extensive research.
Overview
GHK-Cu (Glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide with a strong affinity for copper(II) ions, first identified in human plasma by Dr. Loren Pickart in 1973. The GHK tripeptide is present in human blood, saliva, and urine, with plasma levels declining significantly with age—from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60.
This age-related decline has generated significant research interest, as GHK-Cu has been shown to influence the expression of a remarkably large number of human genes. Broad gene expression studies suggest GHK-Cu can modulate nearly one-third of human genes, with a pattern that shifts gene expression from a damaged or aged state toward a healthier phenotype. Research spans wound healing, skin regeneration, anti-inflammatory effects, hair growth, and tissue remodeling.
Mechanism of Action
GHK-Cu operates through multiple interconnected mechanisms:
- Copper Delivery: GHK-Cu serves as a bioavailable copper carrier, delivering Cu²⁺ ions to cells. Copper is an essential cofactor for numerous enzymes including lysyl oxidase (collagen cross-linking), superoxide dismutase (antioxidant defense), and cytochrome c oxidase (cellular energy production).
- Gene Expression Modulation: Genomic studies have shown GHK-Cu modulates the expression of over 4,000 human genes, including upregulation of genes involved in tissue repair, antioxidant defense, and stem cell activity, while downregulating genes associated with inflammation and tissue destruction.
- Collagen and ECM Remodeling: GHK-Cu stimulates the synthesis of collagen types I, III, and V, as well as decorin, elastin, and glycosaminoglycans, while also promoting controlled degradation of damaged ECM through metalloproteinase regulation.
- Anti-inflammatory Activity: The peptide has been observed to reduce levels of pro-inflammatory cytokines including TNF-alpha, IL-6, and TGF-beta-1 while promoting anti-inflammatory signals.
- Stem Cell Attraction: Research suggests GHK-Cu can attract mesenchymal stem cells and endothelial cells to sites of tissue damage, supporting regenerative processes.
Key Research Findings
- Wound Healing: Multiple studies have demonstrated that GHK-Cu accelerates wound closure, increases collagen deposition, and improves tensile strength in both acute and chronic wound models.
- Skin Regeneration: Clinical trials on topical GHK-Cu have shown improvements in skin thickness, density, and elasticity, with reductions in fine lines and photodamage comparable to or exceeding retinol and vitamin C treatments.
- Gene Expression Studies: Broad Connectivity Map analysis revealed that GHK can modulate 31.2% of human genes, with a net pattern that counters age-related gene expression changes and promotes tissue-repair-associated gene programs.
- Hair Growth: Research has observed that GHK-Cu can enlarge hair follicles, stimulate hair growth, and inhibit 5-alpha reductase, suggesting applications in hair loss research.
- Antioxidant Defense: GHK-Cu has been shown to upregulate antioxidant enzymes and reduce oxidative damage markers in multiple tissue types.
Research Applications
- Skin and Dermatology Research: Anti-aging, wound healing, scar remodeling, and photoprotection studies.
- Tissue Remodeling: Collagen synthesis, ECM remodeling, and fibrosis research.
- Hair Biology: Follicle stimulation and hair growth research.
- Aging Research: Investigating the role of declining GHK-Cu levels in age-related tissue changes and gene expression patterns.
- Anti-inflammatory Research: Studying cytokine modulation and inflammation resolution pathways.
Dosing Protocols (Research Use Only)
The following dosing information reflects common protocols in published research:
| Parameter | Details |
|---|---|
| Injectable Dosage Range | 1 – 5 mg per day |
| Topical Concentration | 0.01% – 1% in cream or serum formulations |
| Frequency | Daily (injectable or topical) |
| Cycle Duration | 4 – 12 weeks (injectable); ongoing (topical) |
| Route | Subcutaneous injection or topical application |
This profile is provided for educational and informational purposes only. GHK-Cu is sold as a research chemical and is not approved by the FDA for human use. All information presented is based on published research literature and should not be construed as medical advice. Always consult qualified professionals before making any decisions related to peptide research.
Ready to Research GHK-Cu?
Get ≥99% purity research-grade peptides with COA from Iron Peak Peptides.